203 related articles for article (PubMed ID: 30721421)
1. Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia.
Lettnin AP; Wagner EF; Carrett-Dias M; Dos Santos Machado K; Werhli A; Cañedo AD; Trindade GS; de Souza Votto AP
Mol Biol Rep; 2019 Apr; 46(2):1873-1884. PubMed ID: 30721421
[TBL] [Abstract][Full Text] [Related]
2. Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines.
Marques DS; Sandrini JZ; Boyle RT; Marins LF; Trindade GS
Leuk Res; 2010 Jun; 34(6):757-62. PubMed ID: 19969351
[TBL] [Abstract][Full Text] [Related]
3. C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters.
Fernandes E Silva E; Figueira FS; Cañedo AD; Machado KS; Salgado MTSF; Silva TK; Wagner EF; Mattozo FH; Lima ÉA; Sales-Neto JM; Ferreira VU; Comitre AA; Mascarenhas SR; Kalil SJ; Votto APS
Biomed Pharmacother; 2018 Oct; 106():532-542. PubMed ID: 29990841
[TBL] [Abstract][Full Text] [Related]
4. The role of stem cell markers in multidrug resistance mediated by ABC transporters.
Tiwari AK; An X; Chen ZS
Leuk Res; 2010 Jun; 34(6):696-7. PubMed ID: 20061021
[No Abstract] [Full Text] [Related]
5. Multidrug resistance phenotype and its relation to stem cell characteristics in chronic myeloid leukemia.
Lettnin AP; Wagner EF; Salgado MTSF; Cañedo AD; Rumjanek VM; Trindade GS; Votto APS
Gene; 2024 Jan; 892():147848. PubMed ID: 37774806
[TBL] [Abstract][Full Text] [Related]
6. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.
Carina V; Zito G; Pizzolanti G; Richiusa P; Criscimanna A; Rodolico V; Tomasello L; Pitrone M; Arancio W; Giordano C
Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671
[TBL] [Abstract][Full Text] [Related]
7. Multi-drug-resistant cells enriched from chronic myeloid leukemia cells by Doxorubicin possess tumor-initiating-cell properties.
Xin H; Kong Y; Jiang X; Wang K; Qin X; Miao ZH; Zhu Y; Tan W
J Pharmacol Sci; 2013; 122(4):299-304. PubMed ID: 23903006
[TBL] [Abstract][Full Text] [Related]
8. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
9. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.
Salustiano EJ; da Costa KM; Freire-de-Lima L; Mendonça-Previato L; Previato JO
J Biol Chem; 2020 May; 295(19):6457-6471. PubMed ID: 32229586
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
Balaji S; Santhi R; Kim U; Muthukkaruppan V; Priya CG; Vanniarajan A
Curr Cancer Drug Targets; 2020; 20(9):710-719. PubMed ID: 32364077
[TBL] [Abstract][Full Text] [Related]
12. Oct4 pseudogenes are transcribed in cancers.
Suo G; Han J; Wang X; Zhang J; Zhao Y; Zhao Y; Dai J
Biochem Biophys Res Commun; 2005 Dec; 337(4):1047-51. PubMed ID: 16229821
[TBL] [Abstract][Full Text] [Related]
13. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
14. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms.
Daflon-Yunes N; Pinto-Silva FE; Vidal RS; Novis BF; Berguetti T; Lopes RR; Polycarpo C; Rumjanek VM
Mol Cell Biochem; 2013 Nov; 383(1-2):123-35. PubMed ID: 23877223
[TBL] [Abstract][Full Text] [Related]
16. c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.
Porro A; Iraci N; Soverini S; Diolaiti D; Gherardi S; Terragna C; Durante S; Valli E; Kalebic T; Bernardoni R; Perrod C; Haber M; Norris MD; Baccarani M; Martinelli G; Perini G
Mol Cancer Res; 2011 Aug; 9(8):1054-66. PubMed ID: 21693596
[TBL] [Abstract][Full Text] [Related]
17. ABCB1 and ABCC1 Function during TGF-β-Induced Epithelial-Mesenchymal Transition: Relationship between Multidrug Resistance and Tumor Progression.
da Costa KM; Freire-de-Lima L; da Fonseca LM; Previato JO; Mendonça-Previato L; Valente RDC
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047018
[TBL] [Abstract][Full Text] [Related]
18. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
19. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
Lee S; Wottrich S; Bonavida B
Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
[TBL] [Abstract][Full Text] [Related]
20. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
